10 PRODUCT ALPHA LABS 1

Alpha Labs’ Aspergillus GM assay recommended by ECMM for screening ventilated COVID-19 patients

With the emergence of COVID-19 there has been a marked increase in patients being admitted into Intensive Care Units (ICU) and particularly those requiring invasive ventilation. In light of this, new guidance has been provided by the European Confederation of Medical Microbiology (ECMM) for the diagnosis and management of patients with acute respiratory distress syndrome […]

11 PRODUCT TSK LABS

TSK Labs offers free patent licenses for their Low Dead Space needles to vaccinate against COVID-19

With a specially developed needle that can potentially save 4 to 8 percent of a precious vaccine, millions more can be vaccinated against COVID-19. To help stop the COVID-19 pandemic, needle manufacturer TSK Laboratory will allow vaccine manufacturers to freely use their patented Low Dead Space technology for administering COVID-19 vaccines.

13 PRODUCT RANDOX

Randox Labs releases whole pathogen multiplex controls to support testing for cold, cough and COVID

Global diagnostics company Randox Laboratories has unveiled a range of whole pathogen multiplex controls that cover multiple viral and bacterial pathogens which cause respiratory disease.

14 PRODUCT ZIATH

Ziath introduces Compact Rack Scanner for easy liquid handling robot integration

Compatible with all 2D barcoded tube racks in SBS format, the Ziath DataPaq Express is the smallest footprint rack scanner currently available.

15 PRODUCT TWO PHOTON RESEARCH

Two-Photon Research develops innovative smartphone test for SARS-CoV-2

Montreal-based Two-Photon Research (TPR) has unveiled CAST, a diagnostics platform that detects the SARS-CoV-2 with a smartphone. The CAST platform uses TPR’s patented Aptamer Molecular Photonic Beacon (AMPB) that photonically interfaces with smartphones. The first application of CAST is for detecting SARS-CoV-2 to help control the COVID-19 pandemic.

16 PRODUCT FUJIFILM

FUJIFILM Irvine Scientific introduces Sterile Express Media Service

FUJIFILM Irvine Scientific has launched a Sterile Express Media Service (SEMS), for small-scale, rapid production of non-GMP media tested for sterility. With SEMS, customers can request up to 100L of media, to be rapidly manufactured in a Grade A/ISO 5 sterile environment, and have it shipped within 15 business days pending sterility confirmation.

1 FEATURED ARTICLE

Digital pathology in the clinical lab

Histopathology is a crucial stage in the diagnosis of many diseases, particularly cancer staging and therapy management. Current challenges facing pathology are a shortage of pathologists and an increasing workload resulting from expanded screening programmes, increased test complexity and an increasing elderly population. Leeds Teaching Hospitals NHS Trust, UK, has a fully subspecialized diagnostic histopathology […]

2 FEATURED ARTICLE

Artificial intelligence is the key driver for digital pathology adoption

by Dr Mustafa Yousif, Dr David S. McClintock and Dr Keluo Yao Artificial intelligence (AI) has the potential to optimize anatomic pathology (AP) laboratory efficiency, enhance pathologists’ diagnostic skills, elevate case reimbursement and, ultimately, improve patient care. To realize this potential, AP laboratories must overcome the barriers to adopting digital pathology (DP) while DP vendors […]

3 FEATURED ARTICLE

Value of calprotectin analysis

by Dr Ruth Ayling Calprotectin is a protein derived from neutrophils and its presence in feces can be used as a surrogate marker of gastrointestinal inflammation. Measurement is useful to differentiate inflammatory bowel disorder (IBD) from functional bowel disease, which has similar clinical features but different etiology, and to manage patients with established IBD.

4 FEATURED ARTICLE

A brief review of heparin-induced thrombocytopenia and diagnostic considerations

by Dr Christina C. Pierre and Dr Lindsay Bazydlo Heparin-induced thrombocytopenia (HIT) is a hypercoagulable disorder that is mediated by antibodies against heparin complexed to platelet factor 4. HIT antibodies activate platelets, which generate a self-propagating, pro-coagulant state. A subset of patients with HIT develop thrombosis that can be limb- and/or life-threatening. This review provides […]